Annual Shareholders Equity
$7.69 M
NaN%
December 1, 2023
Summary
- As of February 9, 2025, CVKD annual stockholders equity is $7.69 million
- During the last 3 years, CVKD annual shareholders equity has risen by +$13.24 million (+238.57%).
- CVKD annual shareholders equity is now at all-time high.
Performance
CVKD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.41 M
-$579.90 K-14.53%
September 1, 2024
Summary
- As of February 9, 2025, CVKD quarterly stockholders equity is $3.41 million, with the most recent change of -$579.90 thousand (-14.53%) on September 1, 2024.
- Over the past year, CVKD quarterly shareholders equity has stayed the same.
- CVKD quarterly shareholders equity is now -60.98% below its all-time high of $8.75 million, reached on September 1, 2023.
Performance
CVKD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CVKD Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +238.6% | 0.0% |
| 3 y3 years | +238.6% | +161.5% |
| 5 y5 years | +238.6% | +161.5% |
CVKD Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +238.6% | -61.0% | +161.5% |
| 5 y | 5-year | at high | +238.6% | -61.0% | +161.5% |
| alltime | all time | at high | +238.6% | -61.0% | +161.5% |
Cadrenal Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.41 M(-14.5%) |
| Jun 2024 | - | $3.99 M(-35.5%) |
| Mar 2024 | - | $6.19 M(-19.5%) |
| Dec 2023 | $7.69 M | $7.69 M(-12.0%) |
| Sep 2023 | - | $8.75 M(+175.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $3.18 M(-21.9%) |
| Mar 2023 | - | $4.07 M(-173.2%) |
| Dec 2022 | -$5.55 M | -$5.55 M(+370.5%) |
| Sep 2022 | - | -$1.18 M(+75.9%) |
| Jun 2022 | - | -$670.80 K |
FAQ
- What is Cadrenal Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics annual shareholders equity year-on-year change?
- What is Cadrenal Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly shareholders equity year-on-year change?
What is Cadrenal Therapeutics annual stockholders equity?
The current annual shareholders equity of CVKD is $7.69 M
What is the all time high annual shareholders equity for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual stockholders equity is $7.69 M
What is Cadrenal Therapeutics annual shareholders equity year-on-year change?
Over the past year, CVKD annual stockholders equity has changed by +$13.24 M (+238.57%)
What is Cadrenal Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CVKD is $3.41 M
What is the all time high quarterly shareholders equity for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly stockholders equity is $8.75 M
What is Cadrenal Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CVKD quarterly stockholders equity has changed by $0.00 (0.00%)